WallStreetZen

NYSE: MRK
Merck & Co Inc Earnings & Revenue

MRK past earnings growth

How has MRK's earnings growth performed historically?
Company
-27.34%
Industry
13.35%
Market
37.62%
MRK's earnings have grown faster (12.04% per year) than the US Drug Manufacturers - General industry average (4.06%)
Performance
MRK's earnings have grown slower (12.04% per year) than the US market average (19.73%)
Performance
MRK's earnings growth is slowing down - its growth over the last year (-27.34%) is below its 5-year compound annual rate (12.04%)
Performance

MRK past revenue growth

How has MRK's revenue growth performed historically?
Company
2.46%
Industry
12.11%
Market
20.3%
MRK's revenue has grown slower (3.97% per year) than the US Drug Manufacturers - General industry average (5.94%)
Performance
MRK's revenue has grown slower (3.97% per year) than the US market average (18.37%)
Performance
MRK's revenue growth is slowing down - its growth over the last year (2.46%) is below its 5-year compound annual rate (3.97%)
Performance

MRK earnings and revenue history

Current Revenue
$48.0B
Current Earnings
$7.1B
Current Profit Margin
14.7%
MRK's has demonstrated consistent long-term earnings growth over the past 10 years (896.43%)
Performance

MRK Return on equity

Current Company
26.1%
Current Industry
35.6%
Current Market
49.8%
MRK's Return on Equity (26.1%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

MRK Return on assets

Current Company
7.9%
Current Industry
6.9%
Current Market
5.4%
MRK is generating higher Return on Assets (7.9%) than the US Drug Manufacturers - General industry average (7.12%)
Performance

MRK Return on capital employed

Current Company
13.66%
Current Industry
11.1%
MRK has gotten more efficient at generating Return on Capital (13.66%) compared to 3 years ago (9.38%)
Performance

MRK earnings dates

Next earnings date
Apr 29, 2021

Merck & Earnings & Revenue FAQ

What were MRK's earnings last quarter?

On Feb 04, 2021, Merck & (NYSE: MRK) reported Q4 2020 earnings per share (EPS) of -$0.83, up 189.25% year over year. Total Merck & earnings for the quarter were -$2.09 billion. In the same quarter last year, Merck &'s earnings per share (EPS) was $0.93.

What was MRK's earnings growth in the past year?

As of Q2 2021, Merck &'s earnings has grown -27.34% year over year. This is 40.7 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 13.35%. Merck &'s earnings in the past year totalled $7.07 billion.

What is MRK's earnings date?

Merck &'s earnings date is Apr 29, 2021. Add MRK to your watchlist to be reminded of MRK's next earnings announcement.

What was MRK's revenue last quarter?

On Feb 04, 2021, Merck & (NYSE: MRK) reported Q4 2020 revenue of $12.52 billion up 5.45% year over year. In the same quarter last year, Merck &'s revenue was $11.87 billion.

What was MRK's revenue growth in the past year?

As of Q2 2021, Merck &'s revenue has grown 2.46% year over year. This is 9.64 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.11%. Merck &'s revenue in the past year totalled $47.99 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.